OMass Therapeutics
Latest round
- Series C
Last raised
- Oct 2026
Total raised
- $511M
Investors
- 15
About OMass Therapeutics
OMass Therapeutics Limited specializes in the development of small molecule therapeutics. Founded in 2016, the company is headquartered in Oxford, UK. It was co-founded by Idlir Liko and Jonathan Hopper, with Ros Deegan serving as the CEO.OMass Therapeutics specializes in developing small molecule therapeutics aimed at treating orphan diseases and immunological conditions. Their product portfolio focuses on validated target ecosystems, such as membrane proteins and intracellular complexes, employing advanced biochemistry, native mass spectrometry, and custom chemistry techniques. Their therapeutics primarily serve patients with immunological disorders and rare diseases that are not adequately treated by existing solutions.In 2023, OMass Therapeutics reported no revenue, with an EBITDA loss of GBP 28,579,921. The company generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research institutions, often involving licensing and collaborative agreements for developing new therapeutics. The company is focused on introducing new products designed to meet unmet medical needs in immunological conditions and orphan diseases. As part of its growth strategy, OMass plans to expand its market reach in Europe, North America, and Asia, aiming for increased engagement with healthcare providers and pharmaceutical companies within these regions.
Who invested in OMass Therapeutics
15 investors across 6 rounds
See all investors in OMass Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OMass Therapeutics
Who invested in OMass Therapeutics?
OMass Therapeutics has 15 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OMass Therapeutics raised?
OMass Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did OMass Therapeutics last raise money?
OMass Therapeutics's most recent round on record is a Series C, in Oct 2026.
What does OMass Therapeutics do?
OMass Therapeutics Limited specializes in the development of small molecule therapeutics.
Where is OMass Therapeutics headquartered?
OMass Therapeutics is headquartered in Oxford, UK.
Which VCs invest in companies like OMass Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at OMass Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like OMass Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.